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CoactivatorPNRC (proline-rich nuclear receptor coregulatory protein) was primarily identiﬁed as a coactivator of nuclear
receptors (NRs) by our laboratory, which enhances NR-mediated transcription by RNA polymerase II. Recent
study has shown that PNRC also stimulates RNA polymerase III-dependent transcription through interaction
with the subunit RPC39 of RNA polymerase III. Here, we report that PNRC accumulates in the nucleolus and its
depletion by small interfering RNA (siRNA) impairs pre-rRNA transcription by RNA polymerase I. We
identiﬁed the sequence at position 94–101 (94PKKRRKKK101) of PNRC as its nucleolar localization sequence
(NoLS). Fusion of this sequence to GFP directed GFP to the nucleolus. Characterization of the NoLS revealed
that the stretches of six successive basic residues are sufﬁcient to function as a NoLS. Through co-
immunoprecipitation assay, we demonstrated that the NoLS is necessary and sufﬁcient to mediate the
association of PNRC with B23/nucleophosmin. Moreover, B23 depletion by siRNA disrupted the accumulation
of PNRC in the nucleolus. Together, our study indicates that PNRC is a novel nucleolar protein that might be
involved in regulation of pre-rRNA synthesis, and it localizes to the nucleolus by interaction with B23 via its
NoLS. Our study also suggests that the stretches of six successive basic residues (lysine and/or arginine) could
function as NoLS.o-2-phenylindole; GFP, green
e; NoLS, nucleolar localization
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Nuclear receptors (NRs) comprise a large class of transcription
factors that play central roles in development, reproduction and
homeostasis [1]. The NRs regulate transcription by binding to
response elements in the promoters of target genes and acting as
scaffolds for the assembly of large coactivator and corepressor
complexes [2]. Ligand-dependent dynamic exchange of corepressors
for coactivators serves as a well-regulated switch from gene
repression to gene activation [3,4].
PNRC (proline-rich nuclear receptor coregulatory protein), a
proline-rich (13.4%) protein with molecular weight of 35.2 kDa, was
primarily identiﬁed as a coactivator by our laboratory [5]. So far it has
been found to interact in a ligand-dependent manner with the ligand-
binding domain of NRs including ERα, ERβ, PR, GR, TR, RARα, RARβ,
RXR, RORα, RORβ, HNF4α, HNF4γ and LRH1, and in a ligand-
independent manner with the orphan receptors SF1, ERRα1 and ERRγ[5,6]. A distinct feature of PNRC as a coactivator is that it interacts with
NRs through a proline-rich Src homology domain-3 (SH3)-binding
motif, S-D (E)-P-P-S-P-S, not through LXXLL motif (NR box) that
mediates the interaction of most coactivators with NRs [5,7].
In addition to enhancing NR-mediated transcription, PNRC has
been found to be capable of down-regulating the activation of Ras and
MAP kinase through interaction with Grb2, an important adapter
protein involved in growth factor/Ras signaling pathway [8]. Our
recent study indicates that PNRC stimulates transcription by RNA
polymerase III through interaction with the subunit RPC39 of RNA
polymerase III [9].
PNRC is widely expressed in human tissues, and its expression is
signiﬁcantly down-regulated in stomach, colorectal, and hepatocel-
lular carcinomas and in breast cancer, implying a possibility of PNRC as
a tumor-related gene and a role in carcinogenesis [8,10–12].
PNRC exerts its functions mainly in the nucleus, and our previous
studies also show that it localizes in the nucleus [5,13]. There is a
putative nuclear localization sequence (NLS) within PNRC, which is
located at position 94–101 (94PKKRRKKK101) [10], and recently we
have conﬁrmed that it is the real NLS of PNRC [14]. Interestingly, when
we studied nuclear localization of PNRC, we found that PNRC is not
homogenously localized in the nucleus, but forms into concentrated
foci that might be the nucleoli. The nucleolus is a distinct subnuclear
compartment in the eukaryotic cell, which is the site of ribosome
biogenesis.
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and identiﬁed its nucleolar localization sequence (NoLS). Moreover,
we revealed that PNRC accumulates in the nucleolus by interaction
with B23/nucleophosmin via its NoLS. Functional analysis indicates
that PNRC might be involved in regulation of pre-rRNA transcription.
2. Materials and methods
2.1. Cell culture
HeLa and MCF-7 cells were cultured at 37 °C, 5% CO2 in minimal
essential medium (MEM) supplemented with 10% fetal bovine serum
(FBS). Cos-7 cells were cultured in Dulbecco's modiﬁed Eagle medium
(DMEM) supplemented with 10% FBS.
2.2. Antibodies
Antibodies used in this study were as follows. For indirect
immunoﬂuorescence assays, mouse monoclonal anti-nucleolin anti-
body (4E2, Abcam), rabbit polyclonal anti-B23 antibody (H-106, Santa
Cruz) and mouse monoclonal anti-FLAG antibody (M2, Sigma) were
used. Alexa Fluor 568-conjugated goat anti-mouse IgG antibody
(Invitrogen) and Alexa Fluor 568-conjugated goat anti-rabbit IgG
antibody (Invitrogen) were used as the secondary antibodies. For
immunoprecipitation, rabbit polyclonal anti-B23 antibody (H-106,
Santa Cruz), rabbit polyclonal anti-nucleolin antibody (N2662, Sigma)Fig. 1. Nucleolar localization of GFP-tagged PNRC. HeLa cells were transfected with the ve
(A) Western blot analysis of the cell extracts using anti-GFP antibody. (B) Fluorescence micr
imaged under a ﬂuorescence microscope. Scale bar, 20 μm. (C) GFP-tagged PNRC colocalizes w
were ﬁxed in cold methanol/acetone (1:1), and then were stained with anti-C23/nucleolin an
DAPI (blue) was used to stain the nucleus. (D) Western blot analysis of the nucleolar an
antibodies.and mouse monoclonal anti-GFP antibody (JL-8, BD living colors)
were used. For Western blot, afﬁnity puriﬁed rabbit anti-PNRC IgGs
for PNRC (generated by our laboratory), rabbit polyclonal anti-B23
antibody (H-106, Santa Cruz) for B23, mouse monoclonal anti-
nucleolin antibody (4i51, Abcam) for nucleolin and mouse monoclo-
nal anti-GFP antibody (JL-8, BD living colors) for GFP or GFP fusion
protein were used.
2.3. Plasmid constructions
All recombinant constructs were veriﬁed by DNA sequencing.
Vectors expressing GFP-tagged wild-type PNRC and GFP-tagged
PNRC186–327 were prepared as previously described [13]. To generate
the vectors expressing GFP-tagged PNRC1–185 and GFP-tagged NLS-
PNRC186–327, the DNA fragments coding PNRC1–185 and NLS-PNRC186–
327 were ampliﬁed by PCR using pEGFP-C1-PNRC as the template and
the following oligonucleotides as the primers (PNRC1–185: 5′-
GATCTCGAGCTATGACTGTCGTCTCCGTCCCG-3′ and 5′-GCCGAATTCT-
CACTTTGATTTTAAAACCTCTT-3′; NLS-PNRC186–327: 5′-GATCTCGAG-
CTCCGAAGAAGCGGCGAAAGAA GAAGATGGGAAAATCGGAGAA-3′
and 5′-GCGTGATCACTAAGTTTGAACTTTGAGGAG-3′). The interest
fragments were cloned in-frame into the XhoI- and EcoRI- or
BamHI-digested pEGFP-C1. To generate the vectors expressing GFP-
tagged PNRCΔNLS and GFP-tagged PNRC mutant (single, double or
triple residues of NoLS were substituted with alanines), the DNA
fragment coding PNRCΔNLS or PNRC mutant was ampliﬁed usingctors expressing GFP or GFP-tagged PNRC, and were analyzed 20 h after transfection.
oscope analysis of subcellular localization of GFP and GFP-tagged PNRC. Live cells were
ith C23/nucleolin. HeLa cells transfected with the vectors expressing GFP-tagged PNRC
tibody as described in Materials and methods and imaged under a confocal microscope.
d nucleoplasmic fractions extracted from MCF-7 cells using anti-PNRC and anti-C23
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method (QuikChange® Site-Directed Mutagenesis Kit, Stratagene)
according to manufacturer's instruction manual, and subcloned in-
frame into pEGFP-C1 through XhoI and BamHI sites (primer sequences
are available on request regarding any of these constructs). To
generate the vector expressing GFP-NoLS, two synthesized oligonu-
cleotides (5′-TCGAGCTCCGAAGAAGCGGCGAAAGAAGAAGTAGG-3′
and 5′-GATCCCTACTTCTTCTTTCGCCGCTTCTTCGGAGC-3′) were
annealed and inserted into XhoI- and BamHI-digested pEGFP-C1. To
construct pEGFP-C1-KKRRKK, pEGFP-C1-KRRKKK, pEGFP-C1-
KKKKKK, pEGFP-C1-RRRRRR and pEGFP-C1-PKKKRKV, two synthe-
sized oligonucleotides for coding the corresponding stretches (the
oligonucleotide sequences are available on request regarding any of
these constructs) were annealed and inserted into XhoI- and BamHI-
digested pEGFP-C1.
2.4. Isolation of nucleoli
Nucleoli were isolated according to the protocol of Lamond's
laboratory (http://www.lamondlab.com/f7nucleolarprotocol.htm).
Brieﬂy, ~1×108 MCF-7 cells were harvested and washed three
times with ice cold PBS, resuspended in 5 ml of buffer A (10 mM
Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT) and
homogenized in Dounce tissue homogenizer until N90% of the cells
were burst (checked under a phase contrast microscope). The nuclei
were centrifuged at 218×g for 5 min at 4 °C and resuspended in 3 ml
S1 solution (0.25 M Sucrose, 10 mM MgCl2), and then layered over
3 ml S2 solution (0.35 M Sucrose, 0.5 mMMgCl2). After centrifugationFig. 2. Knockdown of PNRC expression reduces rRNA synthesis. MCF-7 cells were transfecte
were harvested for extraction of RNA or subjected to metabolic labeling and analysis of rRNA
analysis of rRNA synthesis. Cells were incubated in phosphate-free medium for 2 h andmetab
medium containing 25 mM phosphate for the indicated time in hours. RNA was extracted a
conﬁrm equal loading (B). RNA from the gel was transferred to a Zeta Probe GTmembrane an
mature 28S, 18S, and 5.8S rRNAs are indicated.at 1430×g for 5 min at 4 °C, the nuclei pellet was suspended in 3 ml
S2 solution and then sonicated until there was no intact cells and the
nucleoli were readily observed as dense, refractile bodies (checked
under a phase contrast microscope). The sonicated samples were
layered over 3 ml S3 (0.88 M Sucrose, 0.5 mMMgCl2) and centrifuged
at 3000×g for 10 min at 4 °C. The pellet was the nucleoli, while the
supernatant was nucleoplasmic fraction. The nucleoli were washed
once with 0.5 ml S2 solution. The nucleolar proteins were extracted
from nucleoli using RIPA buffer (150 mM NaCl, 1% NP40, 0.5%
deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0, complete protease
inhibitor cocktail) before subjected to Western blotting analysis.
2.5. siRNA transfection
B23 siRNA (sc-29771) was purchased from Santa Cruz Biotech-
nology Company. C23 siRNA (Nucleolin Stealth RNAi Select;
NCLHSS106985) was purchased from Invitrogen. Negative control
siRNA (cat # 1630) was purchased from Ambion Company. siRNA
transfection was performed using siPORT NeoFX Transfection Agent
(Ambion) according to manufacturer's instructions on reverse
transfection. For Western blot, cells were seeded into 6 cm dishes at
4×105 cells/dish and simultaneously transfected with 8 μl of siPORT
NeoFX (Ambion) and 12 μl 10 μM of siRNA for each dish, according to
the manufacturer's instruction. For immunoﬂuorescense, cells were
seeded into 24-well plate and simultaneously transfected with 1 μl of
siPORT NeoFX (Ambion) and 1.5 μl 10 μM of siRNA for each well,
according to the manufacturer's instruction. At 40 h after transfection,
the cells were harvested for analysis.d with PNRC siRNA or negative control siRNA. Forty-eight hours after transfection, cells
. (A) Evaluation of PNRC siRNA effeciency by northern blot. (B, C) Metabolic labeling and
olically labeledwith [32P]orthophosphate for 75 min, and subsequently chased with the
nd resolved on a 1% agarose/formaldehyde gel, and stained with ethidium bromide to
d analyzed by autoradiography (C). The positions of the 32S precursor rRNAs and of the
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Northern blot for detection of PNRC mRNA was performed as
previously described [9]. Brieﬂy, 20 μg total RNA prepared from siRNA
transfected cells was electrophoresed on 1% agarose-formaldehyde
gels and transferred overnight onto a Zeta Probe GT membrane (Bio-
Rad). A 740-bp human PNRC cDNAwas generated by EcoRI restriction
digestion of pSG5-PNRC plasmid and gel puriﬁcation. One hundred
nanograms of this DNA fragment was radioactively labeled with [α-
32P]dCTP (ICN) using the Megaprime DNA labeling kit (Amersham
Biosciences) and used as probe in hybridization at the concentration
of 2×106 cpm/ml. The membrane was hybridized in ExpressHyb
solution (Clontech) at 68 °C for 1 h after prehybridized according to
the manufacturer's instructions. After washing, the membrane was
exposed to X-ray ﬁlm (Kodak) for 2 days at −70 °C. Afterwards, the
membrane was stripped and re-hybridized with a human beta actin
probe.2.7. Metabolic labeling and analysis of rRNA synthesis
MCF-7 cells were plated on 6 cm dishes and transfected with 5 μl
20 μM of PNRC siRNA, or negative control siRNA using siPORT NeoFX
Transfection Agent (Ambion) according to manufacturer's instruc-
tions. After 48 h, the medium was replaced with phosphate-free
DMEM/20% FBS for 2 h. The cells were then incubated with 40 μCiFig. 3. Identiﬁcation of NoLS of PNRC. (A) Schematic representation of GFP-tagged PNRC mut
blot analysis of the cells transfected with the vectors expressing GFP-tagged PNRC mutants.
mutants. HeLa cells were transfected with the vectors expressing GFP-tagged PNRCmutants,
(1:1) and mounted in DAPI solution, then examined under a confocal microscope. DAPI wa(1.48 mBq) of [32P]orthophosphate (GE Health Care, Piscataway, NJ)
for 75 min. The labeled medium was replaced with phosphate-free
DMEM/20% FBS plus 25 mM phosphate buffer (pH 7.4). Cells were
harvested at the time points as indicated, and RNA was extracted
using TRIZOL (Invitrogen). Equal amounts (6 μg) of total RNA were
separated on a 1.2% agarose/0.8 M formaldehyde gel and stained with
ethidium bromide to conﬁrm equal loading. The RNA was transferred
to Zeta Probe GT membrane (Bio-Rad) using 50 mM NaOH and
analyzed by autoradiography (Bio-Rad, Hercules, CA).2.8. Fluorescence microscopy/immunoﬂuorescence microscopy
Cells were seeded in the 24-well plate and cultured for 18–24 h,
then transfected with 0.3 μg GFP, GFP fusion or FLAG-tagged PNRC
expression vectors using lipofectamine 2000 (Invitrogen). At 20 h
after transfection, live cells or ﬁxed cells were examined under a
ﬂuorescence microscope or a confocal microscope. For ﬁxation, the
cells were washedwith warm PBS and ﬁxed in cold methanol/acetone
(1:1) for 10 min at −20 °C, then mounted in 4′,6-diamidino-2-
phenylindole (DAPI) solution (Vector). For immunoﬂuorescence
assay, the ﬁxed cells were blocked in 5% BSA in 1× TBST for 1 h at
room temperature and incubated with primary antibodies (anti-
nucleolin, anti-FLAG, or anti-B23, 1:100 dilution) overnight at 4 °C.
After 3 times washes with 1× TBST, the cells were incubated with
Alexa Fluor 568-conjugated secondary antibody (1:100) in the darkants. Wild-type PNRC contains 327 aa, and its NLS is localized at aa 94–101. (B)Western
Asterisks represent the interest bands. (C) Subcellular localization of GFP-tagged PNRC
respectively. Twenty hours after transfection, cells were ﬁxed in cold methanol/acetone
s used to stain the nucleus. Scale bar, 20 μm.
Fig. 4. Subcellular localization of GFP and GFP-NoLS. (A) Schematic representation of
GFP-NoLS. (B) HeLa cells were transfected with the vectors expressing GFP or GFP-
NoLS. Live cells were visualized under a ﬂuorescence microscope 20 h after
transfection. Arrowheads indicate the nucleoli. Asterisks represent that GFP does not
accumulate in the nucleolus. Scale bar, 20 μm.
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mounted in DAPI solution and visualized under a ﬂuorescence
microscope or a confocal microscope.
2.9. Co-immunoprecipitation and Western blot
Transiently transfected HeLa cells in 10-cm culture dishes were
lysed in 600 μl lysis buffer (Roche). After preclearing with 40 μl
protein G agarose by incubation for 3 h at 4 °C on a rocking platform,
equivalent amounts of each lysate (~2 mg) were incubated with 3 μg
antibody (anti-B23, anti-nucleolin or anti-GFP antibody) for 1 h
followed by the addition of 30 μl protein G agarose for immunopre-
cipitation overnight at 4 °C with rotation. Immunoprecipitates were
washed three times with 1 ml lysis buffer and the beads were
resupended in 40 μl of sample loading buffer, and boiled for
subsequent Western blot analysis. For Western blot analysis, 10 μl
cell extracts (input) and 20 μl precipitates were separated by 10%
SDS-polyacrylamide gel electrophoresis (PAGE) and detected by
immunoblotting using anti-GFP, anti-nucleolin or anti-B23 antibody
(1:1000) as indicated.
3. Results
3.1. PNRC accumulates in the nucleolus
To investigate subcellular localization of PNRC, we fused its cDNA
to the 3′-end of GFP cDNA. Plasmids encoding either GFP or GFP-
tagged PNRC were transfected into HeLa cells and expression of the
proteins was veriﬁed by Western blotting (Fig. 1A). Subcellular
localization of GFP and GFP-tagged PNRC was examined by ﬂuores-
cence microscopy. As shown in Fig. 1B, GFP was distributed
throughout the cell, whereas GFP-tagged PNRC was predominantly
localized in the nucleus with concentrated foci, which is consistent
with our previous result [13,14]. The foci are likely nucleoli because
they have the characteristic condensed structure of nucleoli visible
under the light microscope [15]. To conﬁrm our observation, we
stained the transfected cells with the antibody against C23/nucleolin,
a major phosphoprotein in the nucleolus. GFP-tagged PNRC co-
localized with C23 (Fig. 1C). The same results were obtained when
plasmids coding GFP-tagged PNRC were transfected into any tested
cells including MCF-7, HEK293, Cos-7 and NIH3T3 cells (data not
shown).
To further conﬁrm nucleolar localization of PNRC, we generated
the vectors expressing FLAG-tagged PNRC and transfected them into
HeLa and Cos-7 cells. Subcellular localization of FLAG-tagged PNRC
was examined by indirect immunoﬂuorescence using anti-FLAG
antibody. The identical result was obtained, FLAG-tagged PNRC was
observed predominantly in nucleus and nucleolus (Supplementary
data, Fig. S1). We also fractionated the nucleoli from MCF-7 cells and
probed the extracted proteins using PNRC antibodies, and found that
endogenous PNRC is presented in the nucleolus (Fig. 1D).
3.2. PNRC depletion by siRNA impairs pre-rRNA transcription
The nucleolus is the site of rRNA biogenesis, in which 28S, 18S and
5.8S rRNA are transcribed as a single precursor (pre-rRNA) and
together with 5S rRNA are processed and assembled into ribosome
subunits. Previous studies indicate that PNRC is involved in tran-
scription by RNA polymerases II and III [5,9]. Therefore, we asked
whether nucleolar protein PNRC is also involved in pre-rRNA
transcription by RNA polymerase I. To test it, PNRC siRNA or negative
control siRNA (control siRNA) was introduced into breast carcinoma
MCF-7 cells, and rRNA synthesis was analyzed by metabolic labeling
of rRNA with [32P] orthophosphate. Northern blotting analysis
validated that introduction of PNRC siRNA markedly reduced PNRC
mRNA level at 48 h post-transfection (Fig. 2A). At 48 h post-transfection, the siRNA-transfected cells were pulsed with [32P]
orthophosphate to label newly synthesized RNA followed by a chase
with cold phosphate. RNA was extracted at different time points
during the chase and analyzed by gel electrophoresis (Fig. 2B) and
autoradiography (Fig. 2C). The same amount (6 μg) of total RNA was
separated on an agarose gel and the labeled newly synthesized rRNA
was visualized by autoradiography. Production of newly synthesized
rRNA was signiﬁcantly reduced in PNRC siRNA-transfected cells when
compared with control siRNA-transfected cells (Fig. 2C), suggesting
that knockdown of PNRC expression impairs pre-rRNA transcription.
3.3. Identiﬁcation of the NoLS
Unlike nuclear localization, nucleolar localization is less well
characterized and no consensus NoLS has been well deﬁned [16]. So
far there is nopublic bioinformatics resource topredictNoLS. Tomap the
NoLS,we ﬁrst cut PNRC into twoparts, amino acids (aa) 1–185 (referred
to as PNRC1–185) and aa 186–327 (referred to as PNRC186–327), and
fused them to the 3′-end of GFP, as illustrated in Fig. 3A. Their
expressions were conﬁrmed by Western blotting (Fig. 3B), and the
subcellular localization was examined under a confocal microscope
after transfected their respective expression vectors into HeLa cells.
As shown in Fig. 3C, GFP-tagged PNRC1–185 was predominantly lo-
calized in the nucleus and the nucleolus, which had the same distri-
bution as GFP-tagged full-length PNRC, whereas GFP-PNRC186–327
distributed throughout the cell, implying that NoLS is within aa 1–185.
To further delineate the NoLS, we generated PNRC mutant with
deletion of NLS (referred to as PNRCΔNLS, Fig. 3A), and observed the
effect of NLS deletion on nucleolar localization of PNRC. GFP-tagged
PNRCΔNLS predominantly localized in the cytoplasm and did not
accumulate in the nucleolus (Fig. 3C), suggesting that the NLS is ne-
cessary for nucleolar localization of PNRC. Since NoLSs are usually
rich in positively charged residues [17], we searched such kind of
sequenceswithin PNRC1–185 and found that onlyNLS (94 PKKRRKKK 101)
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overlaps with NLS in some cases [18–21], we tested whether NLS is
also NoLS for PNRC. To this end, we fused the NLS to PNRC186–327 at
N-terminus (referred to asNLS–PNRC186–327) and examined subcellular
localization of the resulting protein. GFP-tagged NLS–PNRC186–327 was
predominantly localized in the nucleus and the nucleolus (Fig. 3C),
unlike GFP-tagged PNRC186–327 that distributes throughout the cell. The
results suggest that the sequence of 94 PKKRRKKK 101 is also the NoLS of
PNRC.
To further conﬁrm the result, we fused the sequence of
94PKKRRKKK101 directly to GFP at C-terminus (referred to as GFP-
NoLS, as illustrated in Fig. 4A). GFP-NoLS localized predominantly in
the nucleus and nucleolus, whereas GFP was distributed throughout
the cell, but excluded from the nucleolus (Fig. 4B). This result conﬁrms
that the sequence of 94PKKRRKKK101 is sufﬁcient to be a NoLS.Fig. 5. Characterization of the NoLS of PNRC. (A) Schematic representation of the NoLS mut
transfected with the vectors expressing GFP-tagged wild-type PNRC or NoLS-mutated PNRC
cold methanol/acetone (1:1) and stained with anti-C23/nucleolin antibody as described in M
used to stain the nucleus. Scale bar, 10 μm.3.4. Characterization of the NoLS
The NLS/NoLS of PNRC is a stretch of basic residues and its
sequence is quite similar to that of a well-deﬁned monopartite NLS,
SV40 large T antigen (SV40 T) NLS with a sequence of 126PKKKRKV132
(note: aa 94–102 of PNRC is 94PKKRRKKKV102). Nevertheless, SV40 T
NLS is just a NLS, not a NoLS. To reveal functional difference between
these two NLSs and to determine the key residue(s) of NoLS of PNRC,
we ﬁrst mutated every single residue of PNRC NoLS into alanine (the
mutants are referred to as M1–M8, as illustrated in Fig. 5A), and
observed the subcellular localization of these mutants. No single
residue mutation of NoLS affected the nuclear localization of PNRC
(Fig. 5B and data not shown). Changing lysine-100 to alanine (M7)
signiﬁcantly reduced, but did not abolish, the nucleolar localization of
GFP-tagged PNRC (the mutant accumulated in the nucleolus in aboutations. (B) Subcellular localization of GFP-tagged NoLS-mutated PNRC. HeLa cells were
as indicated, respectively. Twenty-four hours after transfection, the cells were ﬁxed by
aterials and methods, and then imaged under a confocal microscope. DAPI (blue) was
Fig. 6. Subcellular localization of GFP fused with six successive basic residues or SV40 T NLS. HeLa cells were transfected with the vectors expressing GFP fused with the stretch of six
successive basic residues as indicated or GFP fused with SV40 T NLS. Live cells were visualized under a ﬂuorescence microscope 20 h after transfection. Arrowheads indicate the
nucleoli. Asterisks represent that GFP or GFP-SV40 T NLS does not accumulate in the nucleolus. Scale bar, 20 μm.
115Y. Wang et al. / Biochimica et Biophysica Acta 1813 (2011) 109–11950% of the transfected cells) (Fig. 5B). The other single-residue
mutations of the NoLS/NLS did not signiﬁcantly alter the nucleolar
localization of GFP-tagged PNRC (data not shown). Together these
results suggest that of the amino acid residues comprising NoLS/NLS
of PNRC, lysine-100 contributes the most to nucleolar localization. On
the basis of mutation of lysine-100, we further mutated lysine-101
into alanine generating the double-residue mutant M9 (also referred
to as K100A, K101A). M9 did not accumulate in the nucleolus, but it
still predominantly localized in the nucleus (Fig. 5B). Our results
indicate that two residues of lysine-100 and lysine-101 are critical for
PNRC NLS to function as a NoLS, but not necessary for it to function as
a NLS. The results suggest that two additional basic residues (K100
and K101) in PNRC NLS compared to SV40 T NLS, may determine that
PNRC NLS could also function as a NoLS.
Since the single-residue mutations P94A and K101A did not alter
nucleolar localization of PNRC, it prompted us to explore the minimal
sequence for NoLS of PNRC. To this end, we generated two more
double-residue mutants M10 (also referred to as P94A, K95A) and
M11 (also referred to as P94A, K101A), and two triple-residue
mutants M12 (also referred to as P94A, K95A, K96A) and M13 (also
referred to as P94A, K95A, K101A), as illustrated in Fig. 5A. Their
subcellular localization was examined using the same method as
above. As shown in Fig. 5B, the double-residue mutants M10 and M11
had no apparent alteration on nucleolar localization compared to
wild-type PNRC, whereas the triple-residue mutants M12 and M13
almost lost accumulation in the nucleolus, suggesting that the stretch
of six successive basic residues (95KKRRKK100 or 96KRRKKK101) is
necessary for being a NoLS. To further conﬁrm the result, we fused six
basic residues to GFP at C-terminus and created the vectors pEGFP-C1-
KKRRKK and pEGFP-C1-KRRKKK as well as pEGFP-C1-KKKKKK and
pEGFP-C1-RRRRRR. We also generated the vector expressing GFP
fused with SV40 T NLS (pEGFP-C1-PKKKRKV) that contained ﬁve
successive basic residues. We transfected HeLa cells with those
vectors, respectively, and examined the subcellular localization of the
resulting fusion proteins. As shown in Fig. 6, all the GFP fused with six
basic residues accumulated in the nucleolus, whereas the GFP fused
with SV40 T NLS did not. Our results imply that the stretches of six
successive basic residues no matter lysine or arginine could be a NoLS.3.5. NoLS mediates the association of PNRC with B23
The nucleolus is a membrane-free organelle in the nucleus, and it
is generally believed that nucleolar localization of a protein results
from its interaction with one of the nucleolar components like rDNA,
rRNA or other nucleolar proteins [16]. Given that no domain of PNRChas been found to interact with nucleic acids and the NoLS determines
the accumulation of PNRC in the nucleolus, we considered that
nucleolar localization of PNRC results from its association with other
nucleolar proteins via its NoLS. Through reviewing the literature, we
noticed that B23/nucleophosmin and C23/nucleolin, two major
nucleolar proteins are able to bind some peptides related to NLS or
NoLS, and are responsible for nucleolar localization of numerous
proteins [22–26]. Therefore, we asked whether nucleolar localization
of PNRC is also associated with B23 or C23.
To test the idea, we ﬁrst investigated the physical interaction
between PNRC and B23 in vivo. HeLa cells were transiently transfected
with vectors expressing GFP or GFP-tagged PNRC and subjected to
reciprocal immunoprecipitation assay. As shown in Fig. 7A, GFP-
tagged PNRC but not GFP was detected in anti-B23 immunoprecipi-
tates. In the reciprocal experiment, B23 was also detected in the anti-
GFP immunoprecipitates from the cells overexpressing GFP-tagged
PNRC (Fig. 7B), suggesting that PNRC is associated with B23 in vivo. To
determine whether NoLS mediates the association of PNRC with B23,
we tested the interaction in vivo between B23 and a NoLS-mutated
PNRC designed M12. As we had shown above, M12 was a NoLS triple-
residue mutant of PNRC (also referred to as P94A, K95A, K96A) as
illustrated in Fig. 5A, and did not accumulate in the nucleolus but still
predominantly localized in the nucleus (Fig. 5B). The interaction
between this PNRC mutant and B23 could not be detected by co-
immunoprecipitation assay (Fig. 7C), suggesting that either NoLS is
required for PNRC to interact with B23 in vivo, or nucleolar
localization is required for PNRC to interact with B23. To further test
whether NoLS mediates the association of PNRC and B23, we
examined whether NoLS alone is sufﬁcient to bind B23. To this end,
HeLa cells were transfected with the vectors expressing either GFP or
GFP-NoLS fusion and subjected to co-immunoprecipitation assay. The
interaction between B23 and GFP-NoLS was detected, whereas the
interaction between B23 and GFP could not be detected (Fig. 7D).
Taken together, NoLS is necessary and sufﬁcient to mediate the
association of PNRC with B23 in vivo.
To determine whether NoLS also mediates the association of PNRC
with C23, we used the same method to investigate the interaction
between PNRC NoLS and C23.We could not detect GFP-NoLS or GFP in
anti-C23 immunoprecipitates (data not shown), suggesting that NoLS
alone is unable or not sufﬁcient to interact with C23.3.6. B23 depletion disrupts the accumulation of PNRC in the nucleolus
As we demonstrated that NoLS is necessary and sufﬁcient to
mediate the nucleolar localization of PNRC and the association of
Fig. 7. NoLS mediates the association of PNRC with B23 in vivo. (A, B) HeLa cells were transfected with the vectors expressing GFP or GFP-tagged PNRC. Twenty hours after
transfection, cell extracts were prepared and subjected to co-immunoprecipitation assay (IP) followed by Western blotting (WB) as described in Materials and methods. (A) Anti-
B23 antibody was used for IP and anti-GFP antibody was used for detection in WB. (B) Anti-GFP antibody was used for IP and anti-B23 antibody was used for detection in WB.
(C) HeLa cells were transfected with the vectors expressing GFP or GFP-tagged NoLS-mutated PNRC (M12, also referred to as P94A, K95A, K96A) and subjected to IP followed byWB.
Anti-B23 antibody was used for IP and anti-GFP antibody was used for detection in WB. (D) HeLa cells were transfected with the vectors expressing GFP or GFP-NoLS fusion and
subjected to IP followed by WB. Anti-B23 antibody was used for IP and anti-GFP antibody was used for detection in WB.
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results from its interaction with B23 via its NoLS. To further provide
the evidence, we tested whether B23 depletion disrupts nucleolar
localization of PNRC. To this end, we ﬁrst generated the HeLa cell line
stably expressing GFP-tagged PNRC by stable transfection and G418
selection, and then transfected the cells with B23 siRNA. Western blot
(Fig. 8A) and immunoﬂuorescence analysis (Fig. 8B) conﬁrmed that
B23 expression was signiﬁcantly reduced after transfection with B23
siRNA. In parallel, the accumulation of GFP-tagged PNRC in the
nucleolus was also decreased when B23 expression was depleted by
B23 siRNA, whereas nuclear localization of GFP-tagged PNRC was not
affected (Fig. 8B). Our results conﬁrm that B23 is required for PNRC to
accumulate in the nucleolus. To test the speciﬁcity, we also knocked
down C23 expression using C23 siRNA in the cell line stably
expressing GFP-tagged PNRC (Fig. 8C). As shown in Fig. 8D, depletion
of C23 had no apparent effect on nucleolar localization of GFP-tagged
PNRC, suggesting that C23 is not required for PNRC to accumulate in
the nucleolus, and the effect of B23 depletion on nucleolar localization
of PNRC is speciﬁc.
4. Discussion
In this study, we demonstrated that PNRC accumulates in the
nucleolus and the sequence of 94PKKRRKKK101 is its NoLS. So far over
4500 human nucleolar proteins that may cover 80% human nucleolar
proteome and more than 200 plant nucleolar proteins have beenidentiﬁed using high-throughput mass-spectrometry-based proteo-
mic techniques, and the databases for human nucleolar proteome
(www.lamondlab.com/NOPdb3.0) [27,28] and plant nucleolar pro-
teome (http://bioinf.scri.sari.ac.uk/cgi-bin/atnopdb/home) have also
been established. Probably due to its very low abundance in some cell
lines and/or its unusual structure or modiﬁcations [e.g. very unusual
high proline content (13.4%)] [10], PNRC was not found in the
previous proteomic studies of the nucleolus, therefore is not included
in the nucleolar proteome databases. Thus, our study adds a new
member to the list of nucleolar proteins.
Although many nucleolar proteins are found to possess NoLS, no
consensus sequence of NoLS has been identiﬁed so far due to the
variety of NoLS [16]. A common feature of most NoLS is a stretch of
positively charged residues [17], and in some cases [18–21], NoLS
overlaps with NLS. Yet, proteins with basic residue repeats do not
always accumulate in the nucleolus [29]. For PNRC, NoLS overlaps
with NLS, and contains the R/K-R/K-X-R/X motif suggested by Weber
et al. [30]. PNRC NoLS/NLS shows great sequence similarity to SV40 T
NLS, which is a well-deﬁned monopartite NLS and does not function
as a NoLS [31,32].
Characterizing the PNRC NoLS/NLS revealed that the stretches of
six successive basic residues but not the stretch of ﬁve successive basic
residues could function as a NoLS, which might explain the function
difference between PNRC NLS/NoLS and SV40 T NLS. Using BLAST of
NCBI to search the proteins that contain the stretches of six successive
basic residues, we found that majority of the proteins bearing those
Fig. 8. Subcellular localization of GFP-tagged PNRC after depletion of B23 or C23 by siRNA. HeLa cells stably expressing GFP-tagged PNRC were transfected with negative control
siRNA or the siRNA against B23 or C23 as indicated. The cells were harvested for Western blotting or subjected to immunoﬂuorescence assay 40 h after transfection. (A) B23 protein
level was determined by Western blotting analysis. Western blotting result was quantiﬁed by calculating the ratio of the density of B23 band and β-actin band (B23/β-actin), right
panel. (B) Confocal microscope analysis of subcellular localization of GFP-tagged PNRC and endogenous B23. The siRNA-transfected cells were ﬁxed in cold methanol/acetone (1:1),
and then were stained with anti-B23 antibody as described in Materials and methods and imaged under a confocal microscope. DAPI (blue) was used to stain the nucleus.
Arrowheads indicate the nucleoli in the bright ﬁeld. (C) C23 protein level was determined by Western blotting analysis. Western blotting result was quantiﬁed by calculating the
ratio of the density of C23 band and β-actin band (C23/β-actin), right panel. (D) Confocal microscope analysis of subcellular localization of GFP-tagged PNRC and endogenous C23.
Scale bar, 20 μm.
117Y. Wang et al. / Biochimica et Biophysica Acta 1813 (2011) 109–119sequences, e.g. ribosomal protein L20 from Vaucheria litorea
(YP_002327536) which contains the KKRRKK sequence (at position
11–16), K-Ras 4B protein [33] that bears KKKKKK, are known to
localize in the nucleolus, but still quite a few proteins containing those
sequences have not been reported to be nucleolar proteins. It is
tempting to speculate that those proteins may localize in the
nucleolus. As described earlier, no consensus sequence has been
identiﬁed so far. Thus, our study gives a new insight into NoLS and
may help to discover new nucleolar proteins.
Since the nucleolus is not bound by membrane, it is generally
believed that nucleolar proteins are retained in nucleolus by docking
to certain nucleolar components such as rDNA, rRNA or nucleolar
proteins [16,34]. Given that many nucleolar proteins contain NoLS, it
is also thought that NoLS meditates high-afﬁnity interactions with
proteins or nucleic acids residing within the nucleolus, which is
responsible for nucleolar localization of the proteins bearing NoLS
[16]. In this study, we showed that B23 was associated with NoLS of
PNRC in vivo. Mutation of NoLS not only reduced nucleolar localization
of PNRC but also disrupted the association of PNRC with B23.
Moreover, knockdown of B23 expression signiﬁcantly reduced the
accumulation of PNRC in nucleolus. These results strongly suggest that
PNRC accumulates in the nucleolus by interaction with B23 via its
NoLS. It is of note that B23 has two splicing variants named B23.1 and
B23.2, the latter of which lacks 35 amino acids at C-terminal and does
not localize in the nucleolus. In this paper, B23 mainly refers to B23.1.B23 is one of themost abundant proteins in the nucleolus, which is
involved in many aspects of ribosome biogenesis, including pre-rRNA
transcription, processing, assembly of ribosomal subunits and
transport of ribosomes [35,36]. Since it could bind many of NoLSs
and retain a wide range of the partner proteins in the nucleolus, B23
has been proposed to a hub protein in the nucleolus [16]. Through
sequestration of many partner proteins e.g. the alterative reading
frame (ARF) [37] and ribosomal protein L23 [38] to the nucleolus, B23
regulates a variety of cell processes such as cell cycle and proliferation.
Given that B23 retains PNRC in the nucleolus, it is likely that B23
might also regulate the functions of PNRC in the nucleoplasm e.g.
modifying NR-mediated transcription and RNA polymerase III-
dependent transcription.
The nucleolus is the site of ribosome biogenesis. Accumulating
evidences show that the nucleolus also has other functions such as
regulations of cell-cycle and cellular stress response, and nucleolar
alteration is always related to cancer and other human diseases [39–
42]. PNRC accumulates in the nucleolus, indicating that it may have a
nucleolar function. Our study showed that knockdown of PNRC by
siRNA impairs pre-rRNA transcription, suggesting that PNRC is
involved in the regulation of pre-rRNA transcription by RNA
polymerase I. It is well documented that steroid hormones regulate
ribosome biogenesis including pre-rRNA transcription [43–46]. For
example, estrogen treatment resulted in both signiﬁcant increased
numbers of nucleolar RNA chains being synthesized and increased
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nucleoli [46]. NRs (steroid hormone receptors) such as ERα, GRβ and
LXR have also been found in the nucleolus [47,48]. Therefore, it is
possible that some NRs directly regulate pre-rRNA transcription by
RNA polymerase I, and PNRC is involved in the process since PNRC is a
coactivator of NRs and localizes in the nucleolus. It is also quite
possible that PNRC, as a coactivator of steroid hormone receptors,
stimulates transcription by RNA polymerase II thus regulating the
expression of transcription factors involving pre-rRNA transcription,
thereby indirectly regulates transcription by RNA polymerase I, as
reported for c-Myc [49]. The c-Myc oncoprotein has been reported to
regulate the activity of RNA polymerases I, II and III. It stimulates pre-
rRNA transcription not only by directly interacting with rDNA [50,51]
but also by regulating the expression of the transcription factors such
as upstream binding factor (UBF) that is required for the pre-rRNA
transcription [49]. Interestingly, (nuclear) actin, which also regulates
transcription by RNA polymerases I, II and III [52–55], binds a lot of
proteins called actin-binding proteins (ABPs) in the nucleus, while
many nuclear ABPs such as Gelsolin and Flightless I are coactivators of
NRs (steroid hormone receptors) [56].
PNRC regulates the transcription by RNA polymerases I, II and III.
Thus, it is quite a special transcriptional factor. Further characteriza-
tion of the mechanisms by which PNRC modulates the transcription
by RNA polymerase I and coordinates the transcription by three RNA
polymerases is important for understanding the functions of PNRC as
well as its roles in cancer and other diseases.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2010.09.017.
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